Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. / Kristensen, Ditte Bech; Prats Gavalda, Clara; Larsen, Steen; Ara, Ignacio; Dela, Flemming; Helge, Jørn W; Larsen, Steen.

In: Acta Diabetologica, 2012.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kristensen, DB, Prats Gavalda, C, Larsen, S, Ara, I, Dela, F, Helge, JW & Larsen, S 2012, 'Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus', Acta Diabetologica. https://doi.org/10.1007/s00592-012-0379-0

APA

Kristensen, D. B., Prats Gavalda, C., Larsen, S., Ara, I., Dela, F., Helge, J. W., & Larsen, S. (2012). Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. Acta Diabetologica. https://doi.org/10.1007/s00592-012-0379-0

Vancouver

Kristensen DB, Prats Gavalda C, Larsen S, Ara I, Dela F, Helge JW et al. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. Acta Diabetologica. 2012. https://doi.org/10.1007/s00592-012-0379-0

Author

Kristensen, Ditte Bech ; Prats Gavalda, Clara ; Larsen, Steen ; Ara, Ignacio ; Dela, Flemming ; Helge, Jørn W ; Larsen, Steen. / Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. In: Acta Diabetologica. 2012.

Bibtex

@article{c2490a4c6d75439e8f70de12a81dae2b,
title = "Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus",
abstract = "This study investigated fiber-type-specific muscle ceramide content in obese subjects and type 2 diabetes patients. Two substudies, one which compared type 2 diabetes patients to both lean- and obese BMI-matched subjects and the other study which compared lean body-matched post-obese, obese, and control subjects, were performed. A fasting blood sample was obtained and plasma insulin and glucose determined. A muscle biopsy was obtained from deltoideus and vastus lateralis, and fiber-type ceramide content was determined by fluorescence immunohistochemistry. Insulin sensitivity estimated by Quicki index was higher in lean compared to type 2 diabetes patients and obese controls. Also in control and post-obese subjects, a higher insulin sensitivity was observed compared to obese subjects. Ceramide content was consistently higher in type I than in type II muscle fibers and higher in deltoideus than vastus lateralis across all groups. No significant differences between groups were observed in ceramide content in either of the two substudies. In human skeletal muscle, ceramide content was higher in type I than in type II fibers in patients with type 2 diabetes and in obese subjects, but overall ceramide muscle fiber content was not different compared to controls.",
author = "Kristensen, {Ditte Bech} and {Prats Gavalda}, Clara and Steen Larsen and Ignacio Ara and Flemming Dela and Helge, {J{\o}rn W} and Steen Larsen",
year = "2012",
doi = "10.1007/s00592-012-0379-0",
language = "English",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus

AU - Kristensen, Ditte Bech

AU - Prats Gavalda, Clara

AU - Larsen, Steen

AU - Ara, Ignacio

AU - Dela, Flemming

AU - Helge, Jørn W

AU - Larsen, Steen

PY - 2012

Y1 - 2012

N2 - This study investigated fiber-type-specific muscle ceramide content in obese subjects and type 2 diabetes patients. Two substudies, one which compared type 2 diabetes patients to both lean- and obese BMI-matched subjects and the other study which compared lean body-matched post-obese, obese, and control subjects, were performed. A fasting blood sample was obtained and plasma insulin and glucose determined. A muscle biopsy was obtained from deltoideus and vastus lateralis, and fiber-type ceramide content was determined by fluorescence immunohistochemistry. Insulin sensitivity estimated by Quicki index was higher in lean compared to type 2 diabetes patients and obese controls. Also in control and post-obese subjects, a higher insulin sensitivity was observed compared to obese subjects. Ceramide content was consistently higher in type I than in type II muscle fibers and higher in deltoideus than vastus lateralis across all groups. No significant differences between groups were observed in ceramide content in either of the two substudies. In human skeletal muscle, ceramide content was higher in type I than in type II fibers in patients with type 2 diabetes and in obese subjects, but overall ceramide muscle fiber content was not different compared to controls.

AB - This study investigated fiber-type-specific muscle ceramide content in obese subjects and type 2 diabetes patients. Two substudies, one which compared type 2 diabetes patients to both lean- and obese BMI-matched subjects and the other study which compared lean body-matched post-obese, obese, and control subjects, were performed. A fasting blood sample was obtained and plasma insulin and glucose determined. A muscle biopsy was obtained from deltoideus and vastus lateralis, and fiber-type ceramide content was determined by fluorescence immunohistochemistry. Insulin sensitivity estimated by Quicki index was higher in lean compared to type 2 diabetes patients and obese controls. Also in control and post-obese subjects, a higher insulin sensitivity was observed compared to obese subjects. Ceramide content was consistently higher in type I than in type II muscle fibers and higher in deltoideus than vastus lateralis across all groups. No significant differences between groups were observed in ceramide content in either of the two substudies. In human skeletal muscle, ceramide content was higher in type I than in type II fibers in patients with type 2 diabetes and in obese subjects, but overall ceramide muscle fiber content was not different compared to controls.

U2 - 10.1007/s00592-012-0379-0

DO - 10.1007/s00592-012-0379-0

M3 - Journal article

C2 - 22350135

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

ER -

ID: 40253549